Patient Access to Cellular Transplant Act or the PACT Act
This bill specifies that payment under Medicare to a hospital for the acquisition costs of an allogeneic hematopoietic stem cell transplant (e.g., bone marrow transplant from a donor) must be made on a reasonable cost basis (similar to the current payment methodology for solid organ acquisitions). The Centers for Medicare & Medicaid Services must determine included items through regulations.
Action Date | Type | Text | Source |
---|---|---|---|
2019-05-01 | IntroReferral | Read twice and referred to the Committee on Finance. | Senate |
2019-05-01 | IntroReferral | Introduced in Senate | Library of Congress |